CTRI/2022/10/046335
Recruiting
Phase 4
A multicentre retrospective study of characterization oftreatment intensified (add on to metformin) real world adultpopulation with type 2 diabetes mellitus in India, Pakistan, and Thailand. - CONVERGE
ovo Nordisk Pharma Gulf FZE0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ovo Nordisk Pharma Gulf FZE
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Informed consent obtained before any study\-related activities (study\-related activities are any procedure related to recording of data according to the protocol).
- •2\.Male or female, age above or equal to 18 years at T2DM diagnosis
- •3\.Year of birth 1928 or later (age \<90 years old in 2017\)
- •4\.T2DM diagnosis in medical record on or after the date of local GLP\-1 RA marketing authorization
- •5\.Medical records documenting prior or ongoing treatment with metformin
- •6\.Medical records documenting treatment with other non\-metformin T2DM drugs
Exclusion Criteria
- •1\.Previous participation in this study. Participation is defined as having given informed consent in this study.
- •2\.Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
- •3\.Patients with any diagnosis of type 1 diabetes mellitus (T1DM)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A retrospective multi-centre analysis investigating the effects of the rate of change in glucose on intermittently scanned continuous glucose monitoring (isCGM) system accuracy in people with type 1 diabetesE10Type 1 diabetes mellitusDRKS00024682niversität BayreuthInstitut für SportwissenschaftenDivision of Exercise Physiology and Metabolism311
Recruiting
Not Applicable
A multicenter retrospective study investigating the safety and efficacy of immune checkpoint inhibitors in lung cancer with interstitial pneumoniaung cancer with interstitial pneumoniaJPRN-UMIN000043974Toho University200
Not yet recruiting
Not Applicable
COVID-19 pneumonia in patients with underlying fatty liverCTRI/2022/03/040908MAX Smart Super specialty Hospital A unit of Gujarmal Modi Hospital
Completed
Not Applicable
A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancerPatients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.JPRN-UMIN000046824niversity of Toyama400
Recruiting
Not Applicable
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206